Tag Archives: Sanofi

FDA stiff-arms Sanofi and Lexicon's Type 1 diabetes hopeful Zynquista

The FDA stiff-armed Sanofi and Lexicon’s diabetes drug Zynquista on Friday, darkening the companies’ hopes of launching the drug for Type 1 diabetes this year. It’s not a complete surprise, because an FDA advisory panel was split right down the middle on whether to approve the SGLT1/2 drug. But the FDA could have chosen the positive side… Read More »

Who'll follow Sanofi CEO Olivier Brandicourt? The company's eyeing candidates now

It’s been a tumultuous four years for Olivier Brandicourt at Sanofi, marked by restructuring, cost cuts, an asset swap and two M&A deals designed to upgrade the drugmaker’s rare disease business. What happens over the next four years is anybody’s guess, but the company’s working now to decide who’ll be at the helm, a spokeswoman said.  Sanofi… Read More »